Complete ALXO Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
ALXO Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 8 peer companies in Healthcare
P/E Ratio
$0.00
-100.0%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.00
-100.0%
Peer Median: 2.4x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for ALXO's business model and current situation.
Multiple Comparison
Multiple | ALXO Current | Peer Median | Peer Average | Premium/Discount | Assessment |
---|---|---|---|---|---|
P/E Ratio | -0.2x | 0.0x | 0.0x | -Infinity% | Undervalued |
EV/EBITDA | Infinityx | 0.0x | 0.0x | Infinity% | Overvalued |
P/S Ratio | Infinityx | 2.4x | 7.5x | Infinity% | Overvalued |
Peer Companies
Click any company to view their valuation
Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
---|---|---|---|---|
$0.03B | 0.0x | 0.0x | 19.1x | |
$0.02B | 0.0x | 0.0x | 0.0x | |
$0.02B | 0.0x | 0.0x | 1.0x | |
$0.03B | 0.0x | 0.0x | 0.0x | |
$0.04B | 0.0x | 0.0x | 109.5x | |
$0.02B | 0.0x | 0.0x | 47.6x | |
$0.03B | 0.0x | 0.0x | 57.7x | |
$0.03B | 0.0x | 0.0x | 2.4x |